These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37837394)

  • 1. The importance of small joint involvement in oligoarticular juvenile idiopathic arthritis.
    Kaplan MM; Ekici Tekin Z; Güngörer V; Çelikel E; Kurt T; Polat MC; Sezer M; Tekgöz N; Karagöl C; Coşkun S; Öner N; Çelikel Acar B
    Mod Rheumatol; 2024 Aug; 34(5):1036-1042. PubMed ID: 37837394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
    Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
    Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication.
    Kaplan MM; Kurt T; Polat MC; Sezer M; Ekici Tekin Z; Çelikel E; Güngörer V; Tekgöz N; Karagöl C; Coşkun S; Öner N; Çelikel Acar B
    Eur J Pediatr; 2023 Oct; 182(10):4557-4564. PubMed ID: 37526705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
    Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
    Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
    Sener S; Aliyev E; Batu ED; Balik Z; Bayindir Y; Cam V; Basaran O; Bilginer Y; Ozen S
    Clin Rheumatol; 2024 Jun; 43(6):2021-2026. PubMed ID: 38683443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fever as an initial manifestation of enthesitis-related arthritis subtype of juvenile idiopathic arthritis: retrospective study.
    Guo R; Cao L; Kong X; Liu X; Xue H; Shen L; Li X
    PLoS One; 2015; 10(6):e0128979. PubMed ID: 26030261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
    Polat MC; Çelikel E; Tekin ZE; Kurt T; Kaplan MM; Güngörer V; Tekgöz N; Sezer M; Karagöl C; Coşkun S; Öner N; Sezer S; Acar BÇ
    Eur J Pediatr; 2024 Jun; 183(6):2725-2731. PubMed ID: 38554171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis.
    Stoll ML; Nigrovic PA; Gotte AC; Punaro M
    Clin Exp Rheumatol; 2011; 29(3):582-8. PubMed ID: 21385553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship?
    Cecchin V; Sperotto F; Balzarin M; Vittadello F; Martini G; Zulian F
    J Paediatr Child Health; 2017 Apr; 53(4):374-377. PubMed ID: 28052441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.
    Eng SWM; Aeschlimann FA; van Veenendaal M; Berard RA; Rosenberg AM; Morris Q; Yeung RSM;
    PLoS Med; 2019 Feb; 16(2):e1002750. PubMed ID: 30807586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
    Anink J; Otten MH; Prince FH; Hoppenreijs EP; Wulffraat NM; Swart JF; ten Cate R; van Rossum MA; van den Berg JM; Dolman KM; Koopman-Keemink Y; Armbrust W; Kamphuis S; van Pelt PA; Gorter SL; van Suijlekom-Smit LW
    Rheumatology (Oxford); 2013 Apr; 52(4):712-7. PubMed ID: 23267169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of joint involvement in juvenile idiopathic arthritis during a 5-year follow-up of newly diagnosed patients: implications for MR imaging as outcome measure.
    Hemke R; Nusman CM; van der Heijde DM; Doria AS; Kuijpers TW; Maas M; van Rossum MA
    Rheumatol Int; 2015 Feb; 35(2):351-7. PubMed ID: 25119829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of active joint count trajectories in juvenile idiopathic arthritis.
    Berard RA; Tomlinson G; Li X; Oen K; Rosenberg AM; Feldman BM; Yeung RS; Bombardier C
    J Rheumatol; 2014 Dec; 41(12):2466-73. PubMed ID: 25274882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER.
    Sahin S; Acari C; Sonmez HE; Kilic FZ; Sag E; Dundar HA; Adrovic A; Demir S; Barut K; Bilginer Y; Sozeri B; Unsal E; Ozen S; Kasapcopur O
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):134. PubMed ID: 34425847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key biomarkers in RF-negative polyarticular and oligoarticular juvenile idiopathic arthritis by bioinformatic analysis.
    Liu Y; Tang X
    Pediatr Rheumatol Online J; 2023 Nov; 21(1):143. PubMed ID: 38001449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children.
    Tiller G; Buckle J; Allen R; Munro J; Gowdie P; Cox A; Akikusa J
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):69. PubMed ID: 30413164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of inactive disease and relapse in oligoarticular juvenile idiopathic arthritis.
    Sezer M; Aydın F; Kurt T; Tekgöz N; Tekin ZE; Karagöl C; Çakar N; Acar B
    Mod Rheumatol; 2021 Sep; 31(5):1025-1030. PubMed ID: 33050742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a composite disease activity score for juvenile idiopathic arthritis.
    Consolaro A; Ruperto N; Bazso A; Pistorio A; Magni-Manzoni S; Filocamo G; Malattia C; Viola S; Martini A; Ravelli A;
    Arthritis Rheum; 2009 May; 61(5):658-66. PubMed ID: 19405003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.